Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Non-Current Deffered Revenue (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Non-Current Deffered Revenue for 3 consecutive years, with $701000.0 as the latest value for Q4 2025.

  • Quarterly Non-Current Deffered Revenue rose 133.67% to $701000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $701000.0 through Dec 2025, up 133.67% year-over-year, with the annual reading at $701000.0 for FY2025, 133.67% up from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 was $701000.0 at SANUWAVE Health, up from $575000.0 in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $701000.0 in Q4 2025, with the low at $215000.0 in Q2 2023.
  • Average Non-Current Deffered Revenue over 3 years is $368666.7, with a median of $343500.0 recorded in 2023.
  • The sharpest move saw Non-Current Deffered Revenue dropped 13.54% in 2024, then soared 133.67% in 2025.
  • Over 3 years, Non-Current Deffered Revenue stood at $347000.0 in 2023, then fell by 13.54% to $300000.0 in 2024, then skyrocketed by 133.67% to $701000.0 in 2025.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $701000.0, $575000.0, and $410000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.